Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04807868 · ClinicalTrials.gov registry record
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
A clinical trial of Non-alcoholic Fatty Liver Disease, sponsored by AdventHealth Translational Research Institute.
- Recruiting
- Registry status
- 1,250
- Enrollment target
- 1
- Study location
NCT04807868: Recruiting study of Non-alcoholic Fatty Liver Disease, sponsored by AdventHealth Translational Research Institute.
NCT04807868 is a study of Non-alcoholic Fatty Liver Disease that is actively recruiting participants, run by AdventHealth Translational Research Institute. The registered enrollment target is 1,250 participants, above the 155-participant average among 57 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (706% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04807868, a study of Non-alcoholic Fatty Liver Disease, is actively recruiting participants, sponsored by AdventHealth Translational Research Institute.
- RECRUITING
- Registry status
- 1,250 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to create a resource that will advance research that is focused on discovery of novel therapies, risk stratification, and aggressive interventions for those at highest risk for non-alcoholic fatty liver disease (NAFLD). To achieve this, we will generate a biobank of liver tissue collected during standard of care liver biopsies. Paired blood/urine samples, FibroScan and relevant data will also be collected.
Conditions Studied
Interventions
- OTHER Biospecimen Collection
- PROCEDURE Standard of care liver biopsy
- OTHER Fibroscan
Study Locations (1)
Florida
- AdventHealth Translational Research Institute - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,250 participants |
| Start Date | 2021-04-22 |
| Est. Completion | 2026-03 |
What NCT04807868 shows while recruiting
NCT04807868 is an observational study that tracks outcomes without assigning an intervention. Its 1,250 participants enrollment target places it among the larger protocols in the corpus, above the 155-participant average among 57 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (706% higher).
The record links to 1 condition, with Non-alcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT04807868 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04807868 about?
NCT04807868 is a clinical study titled "AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)". The purpose of this study is to create a resource that will advance research that is focused on discovery of novel therapies, risk stratification, and aggressive interventions for those at highest risk for non-alcoholic fatty liver disease (NAFLD). To achieve this, we will generate a biobank of live...
What is the current status of trial NCT04807868?
This trial is currently recruiting. The enrollment target is 1,250 participants. The study started on 2021-04-22. Estimated completion is 2026-03.
What conditions does trial NCT04807868 study?
This clinical trial studies the following conditions: Non-alcoholic Fatty Liver Disease.
What interventions are being tested in trial NCT04807868?
The interventions under investigation include: Biospecimen Collection (OTHER), Standard of care liver biopsy (PROCEDURE), Fibroscan (OTHER).
Who is sponsoring clinical trial NCT04807868?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04807868 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-alcoholic Fatty Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04807868's enrollment target sits among peer trials
1,250 1st of 57 the highest of 57 other Non-alcoholic Fatty Liver Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Non-alcoholic Fatty Liver Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RECRUITING · Phase 3
-
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RECRUITING · Phase 3
-
Intermittent Fasting for NAFLD in Adults
RECRUITING · NA
-
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents
RECRUITING · NA
-
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
RECRUITING
-
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT05995821 · 1,250 participants
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
- NCT06024395 · 1,250 participants · NA
A Stepped Care Approach to Treating Dental Fear
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI